| 000 | 04857nam a22003615i 4500 | ||
|---|---|---|---|
| 999 |
_c80722 _d80722 |
||
| 001 | 80722 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230209154702.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 140710s2014 ne | s |||| 0|eng d | ||
| 020 | _a9789401789141 | ||
| 024 | 7 |
_a10.1007/978-94-017-8914-1 _2doi |
|
| 040 | _dES-MaUEC | ||
| 050 | 4 |
_aRC372 _b.I878 2014 |
|
| 245 | 1 | 0 |
_aIssues in Clinical Epileptology : _bA View from the Bench _cedited by Helen E. Scharfman, Paul S. Buckmaster. |
| 260 |
_aDordrecht, Netherlands _bSpringer International Publishing _c2014 |
||
| 300 |
_a1 recurso en línea (XXI, 339 p.) _b50 ilustraciones, 29 ilustraciones en color |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 490 | 0 |
_aAdvances in Experimental Medicine and Biology _x0065-2598 _v813 |
|
| 505 | 0 | _aPreface -- Foreword -- Part I Seizures, epileptiform activities and regional localization -- How can we identify ictal and interictal abnormal activity?- How can we translate “epileptiformâ€{u0863}tivity in vitro into something that is clinically relevant?- What is the importance of abnormal “backgroundâ€{u0863}tivity in seizure generation?- What is a seizure focus?- What is a seizure network? Very fast oscillations at the interface between normal and epileptic brain -- Â{u7A21}t is a seizure network? Long-range network consequences of focal seizures -- Is there any such thing as “generalizedâ€{u0970}ilepsy?- Part II Synaptic plasticity -- Are there really “epileptogenicâ€{u0B65}chanisms or only corruptions of “normalâ€{u0C2C}asticity?- When and how do seizures kill neurons - and is cell death relevant to epileptogenesis?- How is homeostatic plasticity important in epilepsy?- Is plasticity of GABA ergic mechanisms relevant to epileptogenesis?- Do structural changes in GABA neurons give rise to the epileptic state?- Does mossy fiber sprouting give rise to the epileptic state?- Does brain inflammation mediate pathological outcomes in epilepsy?- Are changes in synaptic function that underlie hyperexcitability responsible for seizure activity?- Does epilepsy cause a reversion to immature function?- Are alterations in transmitter receptor and ion channel expression responsible for the epilepsies?- Part III Models and methods -- How do we assess the clinical relevance of models of mesial temporal lobe epilepsy?-Â{u2808}How do we make models that are useful in understanding partial epilepsies?- What non-neuronal mechanisms should be studied to understand epileptic seizures?- What epilepsy comorbidities are important to model in the laboratory? Clinical perspectives -- Understanding epilepsy comorbidities: how can animal models help?- What new modeling approaches will help us identify promising drug treatments?- What are the arguments for and against rational therapy for epilepsy?- How can advances in epilepsy genetics lead to better treatments and cures?- How might novel technologies such as optogenetics lead to better treatments in epilepsy?. | |
| 520 | _aThis book is dedicated to Dr. Philip A. Schwartzkroin.The book has a novel format because it is not intended to be a set of reviews. Instead, it is an effort to explore important topics in the epilepsy research field. Because articles are written by leaders in the field who have years of experience, and individuals with diverse expertise, articles are likely to have a long-lasting impact and be relevant for both epileptologists and neuroscientists.Â{u0075}thorsÂ{u0864}dressÂ{u0D2F}pics that are important, unresolved questions in the field of epilepsy research, drawing on available data from both the bench and the clinic to support their points.Â{u0060}given topic is addressed by one or more authors, each writing from his/her own unique perspective. For all of the individuals who have been trained or worked with Philip Schwartzkroin in the past, and/or have appreciated his contributions to the epilepsy field, this volume is an excellent way to celebrate his achievements and look to the ways they have moved the field forward, and continue to stimulate its growth. | ||
| 650 | 7 |
_2embne _9140489 _aEpilepsia |
|
| 700 | 1 |
_aScharfman, Helen E _eeditor literario _989139 _0Local |
|
| 700 | 1 |
_aBuckmaster, Paul S. _eeditor literario _0Local _989140 |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-017-8914-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 907 |
_a.b12884753 _b10-10-17 _c11-11-15 |
||
| 942 |
_2lcc _cLE |
||
| 945 |
_aRC372 .I878 2014 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i1156457x _z06-04-17 |
||
| 988 | _aEBSPRINGER | ||
| 998 |
_am _a_alco _a_vill _b11-11-15 _cm _dz _e- _feng _gne _h0 |
||